Anagenics Limited reported earnings results for the half year ended December 31, 2023. For the half year, the company reported sales was AUD 6.23 million compared to AUD 5.15 million a year ago. Net loss was AUD 1.95 million compared to AUD 1.46 million a year ago.

Basic loss per share from continuing operations was AUD 0.0037 compared to AUD 0.0024 a year ago. Basic loss per share was AUD 0.0053 compared to AUD 0.0066 a year ago.